Insulet | PODD - 営業利益





営業利益 変化する 日付
Abbott USD 1.36B 775M 2026-09
Align Technology USD 193.04M 1.72M 2026-09
AtriCure USD 4.35M 5.31M 2026-09
Baxter International USD 314M 38M 2026-09
Becton, Dickinson and Co. USD 1.11B 357M 2026-09
Boston Scientific USD 1.01B 232M 2026-09
Cardinal Health USD 819M 5M 2026-09
Cooper Companies USD 222M 253M 2026-06
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 542.7M 23.2M 2026-09
Eli Lilly USD 12.46B 2.68B 2026-06
Globus Medical USD 178.23M 224.2M 2026-09
ICU Medical USD 58.59M 1.84M 2026-09
Inogen USD -7.79M 728K 2024-09
Insulet USD 189.8M 60.1M 2026-09
Integra LifeSciences USD 42.65M 1.36M 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Solventum Corp USD 68M 113M 2026-09
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -2.37M 11.42M 2026-09
Teleflex USD -105.77M 178.84M 2026-09
West Pharmaceutical Services USD -199.7M 378.8M 2026-09
Zimmer Biomet Holdings USD 341.5M 3.2M 2026-09